Targeting synthetic glycopeptides to MGL on Dermal Dendritic cells

ResearchSpace Repository

Show simple item record

dc.contributor.author McIntosh, Julie en
dc.contributor.author Angel, CE en
dc.contributor.author Chen, CJJ en
dc.contributor.author Manning, K en
dc.contributor.author Mansell, Claudia en
dc.contributor.author Agrawai, S en
dc.contributor.author Harris, Paul en
dc.contributor.author Williams, Geoffrey en
dc.contributor.author Squire, Christopher en
dc.contributor.author Brimble, Margaret en
dc.contributor.author Dunbar, Peter en
dc.coverage.spatial Santa Fe Community Convention Center, Santa Fe, New Mexico, USA en
dc.date.accessioned 2012-04-11T23:52:22Z en
dc.date.issued 2011-02-14 en
dc.identifier.citation Dendritic Cells and the Initiation of Adaptive Immunity. 14 Feb 2011 en
dc.identifier.uri http://hdl.handle.net/2292/17104 en
dc.description.abstract The ability of a peptide vaccine to stimulate T cells in vivo might be improved by specifically targeting the peptide to dendritic cells (DC). The C-type lectin Macrophage Galactose-type lectin, MGL (CD301), has been shown to bind to N-acetyl-galactosamine (GalNAc) and small peptides bearing O-linked GalNAc. Synthetic GalNAc can be produced using relatively simple organic chemistry when compared with the complicated branched sugars that are recognised by other C-type lectins. MGL therefore represents a promising target for the design of synthetic peptide vaccines. We have identified that antigen-presenting cells in human skin express MGL and have confirmed that CD14+ dermal DCs might be targeted via MGL. The intracellular fate of MGL following internalisation was tracked by confocal microscopy. MGL traffics through early endosomes to late endosomes/lysosomes, and colocalises with MHC class I and class II. Synthetic glycopeptides were produced incorporating either native O-linked GalNAc or GalNAc residues linked to the peptide chain via non-native “Click” chemistry. Biophysical analysis of the ability of both “Click” and native glycopeptides peptides with recombinant MGL confirmed the ability of both these peptides to bind MGL. Ongoing work aims to determine whether targeting to MGL using these synthetic peptides results in efficient presentation of antigen to T cells. en
dc.description.uri http://www.keystonesymposia.org/meetings/viewPastMeetings.cfm?MeetingID=1102&CFID=5103768&CFTOKEN=52759999 en
dc.relation.ispartof Dendritic Cells and the Initiation of Adaptive Immunity en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.title Targeting synthetic glycopeptides to MGL on Dermal Dendritic cells en
dc.type Conference Poster en
dc.rights.accessrights http://purl.org/eprint/accessRights/RestrictedAccess en
pubs.elements-id 251682 en
pubs.org-id Science en
pubs.org-id Biological Sciences en
pubs.org-id Chemistry en
pubs.org-id Science Research en
pubs.org-id Maurice Wilkins Centre (2010-2014) en
pubs.record-created-at-source-date 2011-12-05 en


Files in this item

There are no files associated with this item.

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Advanced Search

Browse

Statistics